Fibrous Dysplasia is a benign fibro-osseous lesion occurring throughout the skeletal system with a predilection for craniofacial bones, long bones, and ribs. Fibrous dysplasia develops during bone formation and growth with a variable natural evolution. It is considered a genetic nonheritable disease resulting from missense mutations that occur postzygotically in the GNAS1 gene. This mutation leads to a focal congenital failure of proper bone formation and arrest at the woven bone stage. In turn, this leads to a decreased mechanical strength, causing bone pain, pathological fractures, and skeletal deformities. Besides clinical examination, fibrous dysplasia is diagnosed based on the results of radiographic imaging and the microscopic histopathological findings. On CT scan, fibrous dysplasia shows the characteristic "Ground-glass" appearance with well-defined borders. On MRI, fibrous dysplasia has a low signal intensity on T1-weighted MRI and variable signal intensity on T2-weighted MRI. We hereby report a case of an unusual presentation of fibrous dysplasia in a 67-year-old female presenting to the emergency department with generalized malaise and lower limb pain. Fibrous dysplasia may present in the elderly population and can be difficult to differentiate from other malignant and benign lesions affecting the skeletal system.
refused and signed a discharge against medical advice (DAMA) consent, and then came for follow-up to our hospital. The patient was referred to orthopedic oncology services.
Routine biochemical investigations were performed during the initial presentation to the emergency department, and they included hematology and tumor markers; such as Alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigen (CA-125), and cancer antigen (CA 19.9). All biochemical investigations and tumor markers were within normal limits.
Radiological Data
The anteroposterior pelvic radiograph showed a large, expansile lesion with calcification and internal septation at the right iliac bone (Figure 1) . The abdominal and pelvis CT was performed to assess the large right iliac mass lesion. It showed an expansile mass lesion at the right iliac bone measuring about 11.6 x 12.8 x 8 cm ( Figure 2 ). The pelvis MRI showed a mass with well-defined borders which had no medullary or cortical continuation. No other associated soft tissue masses were noted (Figure 3) . Given the age of the patient, location of the lesion, and the radiological appearance, the diagnostic considerations of this lesion included; plasmacytoma, giant cell tumor, and chondromyxoid fibroma.
Upon taking the informed consent of the patient, an ultrasound-guided biopsy of the right pelvic mass was performed. The procedure was performed under aseptic technique. Using coaxial technique, three passes of 16-gauge and seven passes of 18-gauge core biopsy were obtained and sent fresh and in formalin to the pathology department.
Pathology Results
Multiple needle core biopsies were microscopically examined. They revealed curvilinear trabeculae of woven bone within bland fibrous tissue ( Figure 4 ).
The differential diagnosis of low-grade medullary osteosarcoma was ruled out based on MDM2 (Murine Double Minute 2) amplification study. This was carried out using a fluorescence in situ hybridization (FISH) analysis for MDM2 gene amplification status on a paraffin-embedded tissue block using differentially-labeled fluorescent probes targeting the MDM2 gene and the chromosome 12 centromere (CEP12). The targeted cells were evaluated from regions of tumor identified on histopathologic review of a matching hematoxylin and eosin-stained section. The MDM2 amplification came as negative (normal) with an MDM2/CEP12 ratio of 1.1. The average MDM2 signal number per cell was 1.8. The presence of MDM2 amplification (MDM2/CEP12 ratio of ≥ 2.0) is useful for distinguishing osteosarcomas from fibrous lesions. MDM2 amplification (MDM2/CEP12 ratio of 2.0 or greater) is observed in a variety of tumor types.
Since the histomorphology was highly suggestive of fibrous dysplasia, further confirmatory PCR-based DNA sequencing for GNAS mutation limited to exon 8 (including mutation hot spot codon 201) and exon 9 (including mutation hot spot codon 227) of the GNAS gene was performed.
A mutation was detected in codon 201 (CGT to TGT) in exon 8 of the GNAS gene, that changes the encoding amino acid from Arg to Cys (R201C). The Standardized nomenclature for this mutation is "NM_000516: c.601C>T p.Arg201Cys". As such, the final diagnosis of fibrous dysplasia was rendered. It is noteworthy to mention that absence of the GNAS mutation does not essentially rule out fibrous dysplasia as this may occur in tumor mosaicism. In spite of the low sensitivity of the PCR-based DNA sequencing for GNAS, presence of the GNAS mutation can be utilized as a complementary diagnostic tool to detect such mutations that are specific to fibrous dysplasia.
Outcome and Follow-Up:
Further interval radiological studies up to 36 monthswhich included a plain radiograph ( Figure 5 ), pelvis CT ( Figure 6 ), and pelvis MRI ( Figure 7 ) -showed no significant change. The overall morphology and size appeared unchanged upon comparison to the previous radiological studies. Subsequent management included reassurance and observation with annual clinical assessments.
Etiology & Demographics:
Fibrous Dysplasia is a benign fibro-osseous lesion occurring throughout the skeletal system with a predilection for craniofacial bones, long bones, and ribs which develops during bone formation and growth with a variable natural evolution. Fibrous dysplasia can be monostotic {involving one bone} or polyostotic {involving several bones}. The vast majority of cases of fibrous dysplasia are asymptomatic, monostotic lesions that are identified incidentally and managed conservatively by patient education and observation [1] .
Increased incidence of fibrous dysplasia has been noted in patients with McCune-Albright syndrome, a genetic disorder constituting; skin pigmentation, polyostotic fibrous dysplasia, and multiple endocrine dysregulations. At the cellular level, patients diagnosed with McCune-Albright syndrome have an increased activation of adenylate cyclase, leading to a marked cell proliferation and inappropriate cell differentiation. Consequently, a disorganized fibrotic bone matrix is excessively produced, resulting in polyostotic fibrous dysplasia [1] .
Fibrous dysplasia presents at any age during childhood and adulthood, with the majority of cases being detected by the age of 30 years. Worldwide, it affects all racial groups with no gender predilection [1, 2] . Fibrous dysplasia is a genetic nonheritable disease resulting from missense mutations that occur postzygotically in the GNAS1 gene which codes the alpha subunit of the G stimulatory protein, Gs [3] . This mutation leads to a focal congenital failure of proper bone formation and arrest at the woven bone stage. In turn, this leads to a decreased mechanical strength, causing bone pain, pathological fractures, and skeletal deformities [4] .
DISCUSSION
Clinical & Imaging findings: Traditionally, fibrous dysplasia has been considered a disease of childhood, since most symptoms develop within the first two decades of life. After puberty, the dysplastic expansion noted in fibrous dysplasia tends to become quiescent in 60-80% of the patients. Enlargement of the lesion, however, is still unpredictable and has been reported throughout the seventh decade [5] .
The most common presenting symptom noted clinically is an asymmetry of the face caused by a painless enlargement of the craniofacial bones. In long bones, fibrous dysplasia might present as limb pain, malformation of the extremities, or pathological fractures. Furthermore, upon exerting a direct pressure on a neural/cranial nerve foramen or distorting a bony cavity, proptosis, strabismus, tinnitus, facial paralysis might occur [6] .
Besides clinical examination, fibrous dysplasia is diagnosed based on the results of radiographic imaging and the microscopic histopathological findings. Radiologically, the appearance varies with the stage of the lesion and the amount of bony matrix involved. In the early stages, the lesion is welldefined and more radiolucent. Whereas, in the later stages, the lesion becomes more radiopaque [6] . An 8-year-retrospective study which investigated the radiological findings of 14 cases of fibrous dysplasia concluded that the most common radiological sign is "ground-glass" appearance followed by "orange-peel" appearance [7] .
Osteofibrous dysplasia appears histologically different from fibrous dysplasia. The location of the lesion in osteofibrous dysplasia almost always involves the tibia or the fibula with most cases being diagnosed in the first decade of life. Radiologically, osteofibrous dysplasia tends to demonstrate lytic lesions of the proximal tibia. The lesion in osteofibrous dysplasia tends to be intracortical as opposed to medullary in fibrous dysplasia. Given the age of the patient in the present case and the location of the lesion, osteofibrous dysplasia was ruled out.
Treatment & Prognosis:
Although fibrous dysplasia is considered benign with a good prognosis, malignant transformation rarely occurs in less than 1% of all cases. Most fibrous dysplasia malignancies are osteosarcomas arising from craniofacial and monostotic lesions. Radiographically, the most common feature for malignant transformation is the extension of the lesion throughout the bony cortex within the surrounding soft tissue. Therefore, clinicians should keep high index of suspicion for malignancy in any lesion that is rapidly growing, painful, and associated with a rise in serum alkaline phosphatase (ALP) [8] [9] [10] .
Management of fibrous dysplasia can be divided into; observation/conservative management, medical therapy, and surgical therapy (radical excision with remodeling). Surgical treatment options aim to control pain, reduce bony deformities, and prevent pathological fractures from occurring. Surgical procedures are usually postponed until puberty, hoping that the bony lesion might undergo remission [6] . Medical treatment, on the other hand, may include the use of bisphosphates to reduce pain, decrease fracture rates, and improve function in patients diagnosed with symptomatic, polyostotic fibrous dysplasia [1] .
Differential Diagnoses:
Given the age of the patient, location of the lesion, and the radiological appearance of the lesion, the differential diagnoses of fibrous dysplasia include; plasmacytoma, giant cell tumor, and chondromyxoid fibroma:
Plasmacytoma:
Solitary plasmacytoma tends to affect people older than 40 years of age. Patients might present with pain at the affected bone or back pain, if there is involvement of the vertebrae. Plasmacytoma can present as an expansile lytic lesion with aggressive features, such as cortical breakthrough with extra osseous soft tissue.
On plain radiography, plasmacytomas may demonstrate "punched-out" lytic lesions with well-defined borders. On CT scans, plasmacytoma may show subtle lytic lesions that are expansile with cortical breakthrough that might not be visible on plain radiographs. CT features of solitary pelvic plasmacytoma can be divided into: multilocular type, unilocular type and complete osteolytic destruction.
On MRI, plasmacytoma usually demonstrates low T1 signal intensity and high T2 signal intensity. It may show homogenous enhancement and is usually multilocular in appearance. Plasmacytoma usually shows a linear low signal intensity in the soft tissue mass or dark signal of the bone cortex around the mass.
Giant Cell Tumor:
Clinically, giant cell tumors may present with pathological fractures at the site of bony involvement. Decreased range of motion and swelling might be noted at the affected limb. On plain radiographs, the lesion is usually osteolytic, radiolucent, expansile, and eccentrically-located. Giant cell tumors may demonstrate the "soap-bubble" appearance.
On CT scans, giant cell tumor is usually subarticular and eccentric in location. Giant cell tumors tend to be expansile with non-sclerotic margins. The tumor usually demonstrates soft tissue attenuation that may contain foci of hemorrhage or necrosis represented by low attenuation. On MRI, giant cell tumors tend to have heterogenous signal intensities in both T1 and T2. On T2-weighted MRI, low to intermediate heterogenous signal intensities are usually noted in solid areas of the tumor. scans are best for detecting sclerotic margins and lesion's cortical integrity.
On MRI, peripheral nodular enhancement might be seen in the majority of cases upon gadolinium administration. Chondromyxoid fibroma demonstrates low signal intensity on T1-weighted MRI and high signal intensity on T2-weighted MRI.
Fibrous dysplasia may present in the elderly population and can be difficult to differentiate from other malignant and benign lesions affecting the skeletal system. The bony lesion tends to appear well-circumscribed with no periosteal reaction. Serial follow-up assessments may be required to detect possible malignant transformation of fibrous dysplasia. 
Etiology
Missense mutations that occur postzygotically in the GNAS1 gene which codes the alpha subunit of the G stimulatory protein, Gs.
Incidence
The true incidence is unknown. However, it is estimated to be 5-7% of all benign bone tumors.
Gender predilection F=M. Age predilection
Second decade.
Risk factors
Unknown.
Treatment
Observation/conservative management, medical therapy, and surgical therapy.
Prognosis
Good, malignant transformation occurs rarely (<1%).
Findings on imaging
XR: Well-circumscribed lesion with no periosteal reaction. CT: Ground-glass appearance and well-defined borders MRI: Low signal intensity on T1-weighted and variable signal intensity on T2-weighted sequences. • "Ground-glass" appearance. • Well-defined borders.
• Low signal intensity on T1weighted MRI. • Variable signal intensity on T2-weighted MRI.
Plasmacytoma
• Pain at the affected bone.
• "Punched out" lytic lesions. • Well-defined borders.
• Subtle lytic lesions.
• Expansile.
• Cortical breakthrough.
• Low T1 signal intensity.
• High T2 signal intensity.
• Homogenous enhancement.
• Multilocular.
Giant cell tumor
• Pathological fractures at the site of bony involvement. • Decreased range of motion. • Swelling might be noted at the affected limb.
• Radiolucent osteolytic lesions. • Expansile.
• Eccentricallylocated. • Soap-bubble appearance.
• Subarticular and eccentric in location. • Expansile with nonsclerotic margins. • Soft tissue attenuation that may contain foci hemorrhage or necrosis represented by low attenuation.
• Heterogenous signal intensity in both T1 and T2. • On T2-weighted MRI, low to intermediate heterogenous signal intensities are seen in solid areas of the tumor.
Chondromyxoid fibroma
• Limited range of motion. • Chronic, progressive pain in the affected limb. • Rarely, pathological fractures may occur.
• Well-defined.
• Radiolucent.
• Lobulated, eccentric bony lesions.
• May contain calcifications in the lesion that are not readily apparent on radiography.
• Low signal intensity on T1weighted MRI. • High signal intensity on T2-weighted MRI. • Peripheral nodular enhancement post gadolinium administration. 
